Dr. William A. Haseltine
Cloning antibodies from recovered COVID-19 patients is showing promise as a potential treatment for the virus that has affected more than 2.8 million people worldwide and killed at least 196,000.
Dr. William A. Haseltine, Chair and President of ACCESS Health International and former Harvard Medical School professor, told uPolitics that an antibody drug could be approved in the U.S. within four months.
President Donald Trump issued a statement urging Iran to accept a nuclear deal to prevent…
On Saturday, demonstrators across the U.S. participated in organized “No Kings Day” protests, which aimed…
Political activist David Hogg is leaving the Democratic National Committee after announcing he won’t run…
On Sunday, President Donald Trump ordered Immigration and Customs Enforcement (ICE) to expand deportation efforts…
In a meeting with Group of Seven (G7) leaders held on Monday, President Donald Trump…
The Supreme Court announced that it would not grant a hearing to a Second Amendment…
